LIA
CHRS icon

LS Investment Advisors’s Coherus Oncology CHRS Stock Holding History

LS Investment Advisors’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15,154
Closed -$221K – 260
2021
Q1 		$221K Sell
15,154
-895
-6% -$15.2K 0.01% 717
2020
Q4 		$279K Buy
+16,049
New +$286K 0.01% 653
2020
Q3 		– Sell
-2,295
Closed -$41K – 923
2020
Q2 		$41K Buy
+2,295
New +$38.8K ﹤0.01% 1221

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

LS Investment Advisors's CHRS Position: Q2 2021 in Review

LS Investment Advisors sold out of Coherus Oncology (CHRS) in Q2 2021, closing a stake of 15,154 shares — an estimated $221K sold.

LS Investment Advisors first reported a position in CHRS in Q2 2020 and held it in 3 quarters. The position peaked at $279K in Q4 2020. 188 funds tracked by Wall St. Rank hold CHRS as of Q2 2021.

  • LS Investment Advisors reported no remaining Coherus Oncology position as of Q2 2021 after selling out during the quarter.
  • LS Investment Advisors sold 15,154 Coherus Oncology shares in Q2 2021, an estimated $221K.
  • LS Investment Advisors first reported a position in Coherus Oncology in Q2 2020 and held it in 3 quarters.
  • LS Investment Advisors's Coherus Oncology position peaked at $279K in Q4 2020.
  • 188 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2021.

Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.